The Enterprise Value as of December 2025 (TTM) for Nautilus Biotechnology, Inc. (NAUT) is 264.58M

According to Nautilus Biotechnology, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 264.58M. This represents a change of 106.39% compared to the average of 128.20M of the last 4 quarters.

Nautilus Biotechnology, Inc. (NAUT) Historical Enterprise Value (quarterly & annually)

How has NAUT Enterprise Value performed in the past?

The mean historical Enterprise Value of Nautilus Biotechnology, Inc. over the last ten years is 252.55M. The current 264.58M Enterprise Value has changed 10.38% with respect to the historical average. Over the past ten years (40 quarters), NAUT's Enterprise Value was at its highest in in the September 2020 quarter at 1.34B. The Enterprise Value was at its lowest in in the December 2018 quarter at 78.84M.

Nautilus Biotechnology, Inc. (NAUT) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Nautilus Biotechnology, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Nautilus Biotechnology, Inc. (NAUT) Average Enterprise Value

How has NAUT Enterprise Value performed in the past?

The current Enterprise Value of Nautilus Biotechnology, Inc. (NAUT) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Nautilus Biotechnology, Inc. (NAUT) Enterprise Value vs. Peers

How is NAUT’s Enterprise Value compared to its peers?

Nautilus Biotechnology, Inc.’s Enterprise Value is greater than Foghorn Therapeutics Inc. (208.87M), greater than Immuneering Corporation (220.51M), less than Enanta Pharmaceuticals, Inc. (469.35M), less than Pyxis Oncology, Inc. (279.07M), greater than Tenaya Therapeutics, Inc. (184.99M), greater than Zura Bio Limited (113.92M), less than Assembly Biosciences, Inc. (282.59M), greater than Humacyte, Inc. (196.00M), greater than Sagimet Biosciences Inc. (164.48M), greater than Arcturus Therapeutics Holdings Inc. (26.78M),

Build a custom stock screener for Nautilus Biotechnology, Inc. (NAUT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nautilus Biotechnology, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Nautilus Biotechnology, Inc. (NAUT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Nautilus Biotechnology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.